Literature DB >> 22183424

Association of anticytomegalovirus seropositivity with more severe joint destruction and more frequent joint surgery in rheumatoid arthritis.

Matthias Pierer1, Kathrin Rothe, Dagmar Quandt, Anett Schulz, Manuela Rossol, Roger Scholz, Christoph Baerwald, Ulf Wagner.   

Abstract

OBJECTIVE: Expansion of autoreactive CD4+CD28(null) T cells is associated with extraarticular disease manifestations, including rheumatoid vasculitis, and it has recently been demonstrated that expansion of these T cells is associated with anticytomegalovirus (anti-CMV) seropositivity. This study was undertaken to investigate a possible link between latent CMV infection and rheumatoid arthritis (RA).
METHODS: In a retrospective analysis, anti-CMV antibodies and clinical, serologic, and radiologic parameters of joint destruction were examined in 202 RA patients and 272 healthy controls. In addition, frequencies of CD4+CD28(null) T cells; concentrations of the cytokines monocyte chemotactic protein 1 (MCP-1), interferon-α (IFNα), and IFN-inducible protein 10; and anti-CMV-specific T cell responses were analyzed in RA patients.
RESULTS: Overall, no significant difference in the frequency of anti-CMV seropositivity between RA patients and healthy controls was observed. Among individuals older than age 55 years, however, anti-CMV IgG antibodies were significantly more frequent in RA patients than controls (65.3% and 54.7%, respectively; P = 0.05). Anti-CMV seropositivity in RA patients was associated with an increased frequency of CD4+CD28(null) T cells and increased serum concentrations of MCP-1. The frequency of anti-CMV-specific CD4+ T cells producing IFNγ was increased in RA patients compared to controls. Most importantly, anti-CMV-seropositive RA patients showed radiographic evidence of more advanced joint destruction and had increased frequencies of joint-related surgical procedures, indicating more severe joint disease.
CONCLUSION: Our findings indicate that latent CMV infection aggravates the clinical course of RA and is associated with increased frequencies of CD4+CD28(null) T cells and of CMV-specific IFNγ-secreting CD4+ T cells.
Copyright © 2012 by the American College of Rheumatology.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22183424     DOI: 10.1002/art.34346

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  22 in total

1.  How does cytomegalovirus factor into diseases of aging and vaccine responses, and by what mechanisms?

Authors:  Allison E Aiello; Yen-Ling Chiu; Daniela Frasca
Journal:  Geroscience       Date:  2017-06-18       Impact factor: 7.713

2.  Characterization of senescence biomarkers in rheumatoid arthritis: relevance to disease progression.

Authors:  Laura E Petersen; Jaqueline B Schuch; Lucas A de Azeredo; Talita S A Baptista; Julia G Motta; Aline D do Prado; Moisés Evandro Bauer
Journal:  Clin Rheumatol       Date:  2019-06-11       Impact factor: 2.980

3.  [Extra-articular manifestations of rheumatoid arthritis].

Authors:  C Baerwald; C Kneitz; M Bach; M Licht
Journal:  Z Rheumatol       Date:  2012-12       Impact factor: 1.372

4.  Two novel human cytomegalovirus NK cell evasion functions target MICA for lysosomal degradation.

Authors:  Ceri A Fielding; Rebecca Aicheler; Richard J Stanton; Eddie C Y Wang; Song Han; Sepehr Seirafian; James Davies; Brian P McSharry; Michael P Weekes; P Robin Antrobus; Virginie Prod'homme; Fabien P Blanchet; Daniel Sugrue; Simone Cuff; Dawn Roberts; Andrew J Davison; Paul J Lehner; Gavin W G Wilkinson; Peter Tomasec
Journal:  PLoS Pathog       Date:  2014-05-01       Impact factor: 6.823

5.  Latent Cytomegalovirus Infection in Rheumatoid Arthritis and Increased Frequencies of Cytolytic LIR-1+CD8+ T Cells.

Authors:  Kathrin Rothe; Dagmar Quandt; Kristin Schubert; Manuela Rossol; Maria Klingner; Simon Jasinski-Bergner; Roger Scholz; Barbara Seliger; Matthias Pierer; Christoph Baerwald; Ulf Wagner
Journal:  Arthritis Rheumatol       Date:  2016-02       Impact factor: 10.995

6.  Immune response profiling in early rheumatoid arthritis: discovery of a novel interaction of treatment response with viral immunity.

Authors:  John M Davis; Keith L Knutson; Michael A Strausbauch; Abigail B Green; Cynthia S Crowson; Terry M Therneau; Eric L Matteson; Sherine E Gabriel
Journal:  Arthritis Res Ther       Date:  2013       Impact factor: 5.156

7.  Peripheral CD4CD8 double positive T cells with a distinct helper cytokine profile are increased in rheumatoid arthritis.

Authors:  Dagmar Quandt; Kathrin Rothe; Roger Scholz; Christoph W Baerwald; Ulf Wagner
Journal:  PLoS One       Date:  2014-03-25       Impact factor: 3.240

Review 8.  Human cytomegalovirus and autoimmune disease.

Authors:  Anne Halenius; Hartmut Hengel
Journal:  Biomed Res Int       Date:  2014-04-29       Impact factor: 3.411

9.  Low levels of antibodies against common viruses associate with anti-citrullinated protein antibody-positive rheumatoid arthritis; implications for disease aetiology.

Authors:  Natalia Sherina; Hulda S Hreggvidsdottir; Camilla Bengtsson; Monika Hansson; Lena Israelsson; Lars Alfredsson; Karin Lundberg
Journal:  Arthritis Res Ther       Date:  2017-09-30       Impact factor: 5.156

10.  Cytomegalovirus infection exacerbates autoimmune mediated neuroinflammation.

Authors:  Marjan Vanheusden; Bieke Broux; Suzanne P M Welten; Liesbet M Peeters; Eleni Panagioti; Bart Van Wijmeersch; Veerle Somers; Piet Stinissen; Ramon Arens; Niels Hellings
Journal:  Sci Rep       Date:  2017-04-06       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.